Financial Review: Doximity (DOCS) & Its Competitors
by Danessa Lincoln · The Markets DailyDoximity (NYSE:DOCS – Get Free Report) is one of 44 publicly-traded companies in the “Services – Computer Programming And Data Processing” industry, but how does it weigh in compared to its rivals? We will compare Doximity to similar companies based on the strength of its risk, profitability, institutional ownership, valuation, analyst recommendations, earnings and dividends.
Valuation and Earnings
This table compares Doximity and its rivals top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Doximity | $570.40 million | $223.18 million | 32.23 |
| Doximity Competitors | $282.47 million | -$64.10 million | -8.50 |
Doximity has higher revenue and earnings than its rivals. Doximity is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Institutional and Insider Ownership
87.2% of Doximity shares are held by institutional investors. Comparatively, 56.8% of shares of all “Services – Computer Programming And Data Processing” companies are held by institutional investors. 31.3% of Doximity shares are held by company insiders. Comparatively, 22.3% of shares of all “Services – Computer Programming And Data Processing” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Risk & Volatility
Doximity has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Doximity’s rivals have a beta of 0.80, meaning that their average stock price is 20% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings and target prices for Doximity and its rivals, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Doximity | 0 | 2 | 2 | 2 | 3.00 |
| Doximity Competitors | 89 | 194 | 215 | 11 | 2.29 |
Doximity currently has a consensus target price of $55.00, suggesting a potential upside of 35.43%. As a group, “Services – Computer Programming And Data Processing” companies have a potential upside of 93.79%. Given Doximity’s rivals higher probable upside, analysts clearly believe Doximity has less favorable growth aspects than its rivals.
Profitability
This table compares Doximity and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Doximity | 40.72% | 24.63% | 21.30% |
| Doximity Competitors | -51.08% | -912.69% | -63.05% |
Summary
Doximity beats its rivals on 11 of the 13 factors compared.
About Doximity
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.